Search Results - "van Oostveen, Wieke"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring by van Oostveen, Wieke M, de Lange, Elizabeth C M

    “…Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting many individuals worldwide with no effective treatment to date. AD is…”
    Get full text
    Journal Article
  2. 2

    Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors by Sijben, Hubert J., van Oostveen, Wieke M., Hartog, Peter B. R., Stucchi, Laura, Rossignoli, Andrea, Maresca, Giovanna, Scarabottolo, Lia, IJzerman, Adriaan P., Heitman, Laura H.

    Published in Scientific reports (10-06-2021)
    “…The human norepinephrine transporter (NET) is an established drug target for a wide range of psychiatric disorders. Conventional methods that are used to…”
    Get full text
    Journal Article
  3. 3

    Label-free detection of prostaglandin transporter (SLCO2A1) function and inhibition: insights by wound healing and TRACT assays by Mocking, Tamara A M, van Oostveen, Wieke M, van Veldhoven, Jacobus P D, Minnee, Hugo, Fehres, Cynthia M, Whitehurst, Charles E, IJzerman, Adriaan P, Heitman, Laura H

    Published in Frontiers in pharmacology (09-05-2024)
    “…The prostaglandin transporter (PGT, SLCO2A1) mediates transport of prostanoids (a.o. prostaglandin E2 (PGE )) into cells and thereby promotes their…”
    Get full text
    Journal Article
  4. 4

    Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases by van Oostveen, Wieke M, Huizinga, Tom W J, Fehres, Cynthia M

    Published in Immunological reviews (09-09-2024)
    “…Systemic sclerosis (SSc) is a severe autoimmune disease characterized by vasculopathy, fibrosis, and dysregulated immunity, with hallmark autoantibodies…”
    Get full text
    Journal Article
  5. 5